| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |